Ammi visnaga 6X • Aralia racemosa 6X • Cardiospermum halicacabum 6X • Galphimia Glauca 6X • Larrea mexicana 6X • Luffa operculata 6X • Okoubaka 6X. Other Ingredients: Ethanol (96%), Dibasic Sodium Phosphate, Monobasic Dihydrate Sodium Phosphate, Water.
Brand name products often contain multiple ingredients. To read detailed information about each ingredient, click on the link for the individual ingredient shown above.
In 2004, Canada began regulating natural medicines as a category of products separate from foods or drugs. These products are officially recognized as "Natural Health Products." These products include vitamins, minerals, herbal preparations, homeopathic products, probiotics, fatty acids, amino acids, and other naturally derived supplements.
In order to be marketed in Canada, natural health products must be licensed. In order to be licensed in Canada, manufacturers must submit applications to Health Canada including information about uses, formulation, dosing, safety, and efficacy.
Products can be licensed based on several criteria. Some products are licensed based on historical or traditional uses. For example, if an herbal product has a history of traditional use, then that product may be acceptable for licensure. In this case, no reliable scientific evidence is required for approval.
For products with non-traditional uses, some level of scientific evidence may be required to support claimed uses. However, a high level of evidence is not necessarily required. Acceptable sources of evidence include at least one well-designed, randomized, controlled trial; well-designed, non-randomized trials; cohort and case control studies; or expert opinion reports.
Finished products licensed by Health Canada must be manufactured according to Good Manufacturing Practices (GMPs) as outlined by Health Canada.
This is a homeopathic preparation. Homeopathy is a system of medicine established in the 19th century by a German physician named Samuel Hahnemann. Its basic principles are that "like treats like" and "potentiation through dilution." For example, in homeopathy, diarrhea would be treated with an extreme dilution of a substance that normally causes diarrhea when taken in high doses.
Practitioners of homeopathy believe that more dilute preparations are more potent. Many homeopathic preparations are so diluted that they contain little or no active ingredient. Therefore, most homeopathic products are not expected to have any pharmacological effects, drug interactions, or other harmful effects. Any beneficial effects are controversial and cannot be explained by current scientific methods.
Dilutions of 1 to 10 are designated by an "X." So a 1X dilution = 1:10, 3X=1:1000; 6X=1:1,000,000. Dilutions of 1 to 100 are designated by a "C." So a 1C dilution = 1:100; 3C = 1:1,000,000. Dilutions of 24X or 12C or more contain zero molecules of the original active ingredient.
Homeopathic products are permitted for sale in the US due to legislation passed in 1938 sponsored by a homeopathic physician who was also a Senator. The law still requires that the FDA allow the sale of products listed in the Homeopathic Pharmacopeia of the United States. However, homeopathic preparations are not held to the same safety and effectiveness standards as conventional medicines. For more information, see the Homeopathy monograph.
Below is general information about the effectiveness of the known ingredients contained in the product A. Vogel Pollinosan (Spray). Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
There is insufficient reliable information available about the effectiveness of chaparral.
INSUFFICIENT RELIABLE EVIDENCE to RATE
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product A. Vogel Pollinosan (Spray). Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
There is insufficient reliable information available about the safety of American spikenard.
PREGNANCY: POSSIBLY UNSAFE
when used orally; avoid using (12).
LACTATION:
Insufficient reliable information available; avoid using.
LIKELY UNSAFE ...when used orally. There are several reports of serious poisoning, acute hepatitis, and kidney and liver damage, including irreversible renal and hepatic failure (568,569,570,571,3484,3497,11121,11122,11129,41416,41445).
PREGNANCY AND LACTATION: LIKELY UNSAFE
when used orally.
There are several reports of serious poisoning, acute hepatitis, and kidney and liver damage, including irreversible renal and hepatic failure (568,569,570,571,3484,3497,11121,11122,11129,41416,41445). Advise patients not to use products containing chaparral.
POSSIBLY SAFE ...when used orally and appropriately in medicinal amounts, short-term. Galphimia glauca extract standardized to contain galphimine B 0.35-0.7 mg, has been used with apparent safety in clinical research for up to 15 weeks (26542,99507).
PREGNANCY AND LACTATION:
Insufficient reliable information available.
POSSIBLY UNSAFE ...when used orally in high doses or for an extended duration. High doses of khella or use over an extended period of time can cause increases in liver enzymes and possible liver damage (2). There is insufficient reliable information available about the safety of khella when applied topically.
PREGNANCY: LIKELY UNSAFE
when used orally.
The active constituent, khellin, has uterine stimulant activity (19); contraindicated.
LACTATION:
Insufficient reliable information available; avoid using.
Below is general information about the interactions of the known ingredients contained in the product A. Vogel Pollinosan (Spray). Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Theoretically, chaparral might have additive adverse effects on the liver when used with hepatotoxic drugs (568,569,570,571,3497,11121,11122).
|
Theoretically, taking Galphimia glauca with CNS depressants may increase the risk of sedation.
Details
|
Theoretically, khella might decrease the effectiveness of cardiac glycosides like digoxin. The khella constituent visnadin has negative inotropic effects that might counter the effects of cardiac glycosides (19,869).
|
Theoretically, khella might have additive adverse effects on the liver when used with hepatotoxic drugs. Khella can increase liver transaminases (2,2522). Some drugs that can adversely affect the liver include acetaminophen (Tylenol), amiodarone (Cordarone), carbamazepine (Tegretol), isoniazid (INH), methotrexate (Rheumatrex), methyldopa (Aldomet), and many others.
|
Theoretically, concomitant use might result in increased photosensitivity. Khella constituents can cause photosensitivity (2521,7162). Some drugs that cause photosensitivity include amitriptyline (Elavil), quinolones (Ciprofloxacin, others), sulfa drugs (Septra, Bactrim, others), and tetracycline.
|
Below is general information about the adverse effects of the known ingredients contained in the product A. Vogel Pollinosan (Spray). Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General ...No adverse effects have been reported; however, a thorough evaluation of safety outcomes has not been conducted.
General
...Chaparral is generally regarded as unsafe for use.
Any benefits of therapy may not outweigh the risk of toxicity. Orally, chaparral can cause hepatoxicity, resulting in jaundice, fatigue, right upper quadrant abdominal pain, dark urine, light stools, nausea, diarrhea, weight loss, fever, and anorexia (568,569,570,571,3497,11121,11122). It can also cause cirrhosis, cholestasis, cholangitis, acute hepatitis, and liver failure possibly necessitating liver transplant (3497). Consumption of chaparral tea has been associated with cystic renal disease and cystic adenocarcinoma of the kidney (11129). Although some information suggests that low doses of chaparral can be used safely, a safe dose has not been established (10417).
Topically, chaparral can cause contact dermatitis (11128).
Hepatic
...Orally, chaparral can cause hepatoxicity, resulting in jaundice, fatigue, right upper quadrant abdominal pain, dark urine, light stools, nausea, diarrhea, weight loss, fever, and anorexia.
It can also cause cirrhosis, cholestasis, cholangitis, acute hepatitis, and liver failure (3497) Multiple cases of severe hepatotoxicity have been reported, including at least two cases requiring liver transplant (568,569,570,571,3497,11121,11122,41416,41445,41464).
The nordihydroguaiaretic acid (NDGA) constituent of chaparral is thought to be responsible for its hepatotoxic effect; however, the exact mechanism of toxicity is unknown (11125). Although some information suggests that low doses of chaparral can be used safely, a safe dose has not been established (10417).
Immunologic ...Topically, chaparral can cause contact dermatitis (10417,11128,41434).
Renal ...Orally, chaparral can cause kidney failure (3497). Consumption of chaparral tea has been associated with cystic renal disease and cystic adenocarcinoma of the kidney. In one case report, consumption of 3-4 cups of chaparral tea daily was associated with these symptoms (11129).
General
...Orally, Galphimia glauca seems to be well tolerated.
Most Common Adverse Effects:
Orally: Epigastric burning, headache, nausea, sedation.
Gastrointestinal ...Orally, Galphimia glauca extract 7-14 mg daily has been associated with nausea and epigastric burning (99507).
Neurologic/CNS ...Orally, Galphimia glauca extract 7-14 mg daily has been associated with sedation and headache. Rarely, restlessness, nervousness, weakness, and other side effects have been reported; but it is unclear if Galphimia glauca was the causal factor (99507).
General ...Orally, prolonged use or use of high doses of khella can cause nausea, dizziness, constipation, lack of appetite, headache, itching, and insomnia. In some patients, khella can cause elevated liver transaminase and gamma-glutamyltransferase (GGT) levels (2). There is also some concern that khella might cause photosensitivity (2,7162).
Dermatologic ...Orally, prolonged use or use of high doses of khella can cause itching (2). There is also some concern that khella might cause photosensitivity because of the constituents khellin and furocoumarin (2,7162).
Gastrointestinal ...Orally, prolonged use or use of high doses of khella can cause nausea, constipation, and lack of appetite (2).
Hepatic ...Orally, in some patients, prolonged use or use of high doses of khella can cause elevated liver transaminase and gamma-glutamyltransferase (GGT) levels (2), probably due to its khellin constituent, which is known to affect liver enzymes (6,2522).
Neurologic/CNS ...Orally, prolonged use or use of high doses of khella can cause dizziness, headache, and insomnia (2).